Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Flush With Fresh Funds, ReViral CEO Outlines RSV Trial Plans
Aug 01 2018
•
By
Sten Stovall
ReViral to test RV521 in babies aged one to 24 months. • Source: Shutterstock
More from Financing
More from Business